Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Clinical trial NCT06065046 · RECRUITING

Trial details

NCT number: NCT06065046
Sponsor: Tang-Du Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Traumatic Brain Injury

Start date: 2023-11-24
Primary completion: 2026-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.